Bisoprolol in ischaemic heart disease — examples of use in clinical practice
Author(s) -
Marcin Barylski
Publication year - 2016
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.5603/kp.2016.0133
Subject(s) - bisoprolol , medicine , nebivolol , cardiology , carvedilol , coronary artery disease , vasodilation , drug , ischaemic heart disease , heart failure , blood pressure , pharmacology
Bisoprolol belongs to the modern β-adrenolytics without vasodilators properties, being also highly cardioselective drug. In contrast to third generation β -adrenolytics (nebivolol, carvedilol), bisoprolol much more effectively and quickly reduces heart rate, and therefore we should use it when we think about more effective control of heart rate, which is extremely important in patients with coronary heart disease. This paper presents the case histories of patients with coronary artery disease who were treated with bisoprolol.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom